![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Asunaprevir Does Not Have an Effect on QTcF Interval in Healthy Subjects
|
|
|
Reported by Jules Levin
15th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy. Washington DC, May 19-21, 2014. Eley T,1 Colston E,1 Li J,2
Garimella T,1 He B,1 Dutta A,1 Kandoussi H,3 Bertz R1
1Bristol-Myers Squibb Research and Development, Hopewell, NJ; 2Pharmacyclics Incorporated, Sunnyvale, CA; 3Bristol-Myers Squibb Research and Development, Lawrenceville, NJ
![Pharm1.gif](../images/052314/052314-8/Pharm1.gif)
![Pharm2.gif](../images/052314/052314-8/Pharm2.gif)
![Pharm3.gif](../images/052314/052314-8/Pharm3.gif)
![Pharm4.gif](../images/052314/052314-8/Pharm4.gif)
![Pharm5.gif](../images/052314/052314-8/Pharm5.gif)
![Pharm6.gif](../images/052314/052314-8/Pharm6.gif)
![Pharm7.gif](../images/052314/052314-8/Pharm7.gif)
![Pharm8.gif](../images/052314/052314-8/Pharm8.gif)
![Pharm9.gif](../images/052314/052314-8/Pharm9.gif)
![Pharm10.gif](../images/052314/052314-8/Pharm10.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|